Clinical trial Recruiting at 1 site Interventional Ages 18 and up Women only

Using optical imaging to differentiate breast tissue types

Official title: Breast Cancer Diagnosis Using Optical Techniques

Run by Region Skane · NCT06857669 · Data updated 2026-11-12

This study is testing new light-based imaging methods to see if they can safely tell the difference between healthy, benign, and cancerous breast tissues in patients with confirmed tumors.

Quick facts

Study typeInterventional
Ages18 Years and up
SexWomen only
Enrollment90 (estimated)
SponsorRegion Skane
Academic / other
Drugs / interventionschemotherapy, radiation
Locations1 site (Malmö)
StatusRecruiting
StartedDecember 1, 2020
Main results expectedDecember 31, 2026
Study endsMay 30, 2027
Registry record updatedApril 29, 2026
Trial IDNCT06857669 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates for this study are women with solitary biopsy-verified breast tumors larger than 1 cm.

Probably not a fit

Patients who have undergone previous breast surgery or received neoadjuvant chemotherapy may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study evaluates the effectiveness of diffuse reflectance spectroscopy and photoacoustic imaging as non-invasive diagnostic tools for differentiating between healthy, benign, and malignant breast tissues. By analyzing the unique optical profiles of these tissue types, the research aims to provide a safer alternative to traditional diagnostic methods like mammography and biopsies, which can be uncomfortable and expose patients to radiation. The study will focus on patients with biopsy-verified tumors larger than 1 cm, assessing the feasibility of these optical techniques in clinical settings.

Why it matters

Potential benefit: If successful, this approach could lead to safer, non-invasive diagnostic methods for breast cancer detection and monitoring.

How similar studies have gone: While the use of optical imaging techniques is gaining interest, this specific combination of diffuse reflectance spectroscopy and photoacoustic imaging for breast tissue analysis is relatively novel.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* solitary malignant or benign biopsy verified tumour \> 1 cm
* understands written and oral Swedish

Exclusion Criteria:

* previous breast surgery
* has received neoadjuvant chemotherapy
* skin burns in on the chest

Where it's running

  • Skane University Hospital
    Malmö, Sweden
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.